CA Patent

CA1327360C — Oxo-analogs of mevinolin-like antihypercholesterolemic agents

Assigned to Merck and Co Inc · Expires 1994-03-01 · 32y expired

What this patent protects

TITLE OF THE INVENTION OXO-ANALOGS OF MEVINOLIN-LIKE ANTIHYPER-CHOLESTEROLEMIC AGENTS ABSTRACT OF THE INVENTION Mevinolin-like compounds in which the lactone is opened and the hydroxyl function produced thereby is replaced by an oxo function are potent HMG-CoA …

USPTO Abstract

TITLE OF THE INVENTION OXO-ANALOGS OF MEVINOLIN-LIKE ANTIHYPER-CHOLESTEROLEMIC AGENTS ABSTRACT OF THE INVENTION Mevinolin-like compounds in which the lactone is opened and the hydroxyl function produced thereby is replaced by an oxo function are potent HMG-CoA reductase inhibitors possessing one less asymmetric center.

Drugs covered by this patent

Patent Metadata

Patent number
CA1327360C
Jurisdiction
CA
Classification
—
Expires
1994-03-01
Drug substance claim
No
Drug product claim
No
Assignee
Merck and Co Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.